IT News Market News IT News
Max Wolf | 05/28/2020
On May 25-26, the International Congress of Health Organization 2020 was held online. The problems of the pandemic world and the construction of a post-quarantine future were discussed.
According to the Minister of Health Mikhail Murashko, the health situation is affected by the behavior of citizens no less than the work of doctors. From this we can conclude that since the ministry
aware of this fact, then sooner or later they will bring such knowledge to the masses.
New realities require total training for health workers. By 2024, the full involvement of all health workers in the process of continuing medical and pharmaceutical education is planned,
introduced today by the Ministry of Health, including through a specialized portal. From 560 thousand specialists in 2020, the number of continuously studying should grow to 1 million 880 thousand people.
The international status of the Organizational Health Forum 2020 was ensured by the participation of the Association of International Pharmaceutical Manufacturers. Its representatives already today speak of their industry as a global driver.
economics. Any driver is useful last today. The conditions are created for simplified registration of the most popular pharmaceutical products and their expedited deliveries, optimized for
this regulation and electronic document management.
Of course, do not forget that the “simplified” is an excellent incentive, first of all, for global companies. Due to their technological readiness and scale of production, they are able to quickly
master new niches, which then fall into voluntary or involuntary dependence on large corporations.
The innovative agenda of the Health Organization was adorned by the presentation of Alexander Pirozhenko, Deputy Director General of the Agency for Strategic Initiatives, implementing a project to create a digital platform
to share best practices. Pirozhenko mentioned the Dutch experience as a guideline. In this country seven clinics set up data exchange to evaluate the average treatment outcomes of different
diseases and on the basis of this to establish – where it was possible to improve them, whether this experience can be replicated, including in the form of new standards. Similar collaboration has already led, in
in particular, to improve the results of treatment of breast cancer.
In Russia, they decided to create their own platform for combining best practices. While it, the truth is little reminiscent of the Netherlands. The fact is that we do not have a large number of organizations wishing
voluntarily exchange objective data, at the same time risking looking worse than colleagues. In the Netherlands, they found an incentive for this – based on a joint analysis (where poor performance is just as important,
than good ones, otherwise you cannot establish the truth) they develop new standards that improve both the overall picture and the processes in specific clinics. The Russian platform, at least at the current stage, is larger
recalls the Digital Exhibition of Achievements of National Economy. Here, various organizations presented dissimilar, but rather striking achievements: Muscovites shared their management experience
the life cycle of expensive equipment, specialists from Kirov and the region – methods of increasing the availability of drugs (drug reimbursement), Tatarstan boasted of mobile clinics.
It is unclear, however, where the Dutch experience of establishing a regular exchange of data and their joint analysis by participants in the information collection process hid here. Ok, we have a historical habit of choice
its own unique path to success. We will probably one way or another, but we will also come to the best practices digitized as they should. Moreover, the Agency for Strategic Initiatives explains that the main
problems associated with the task of generating (or even aggregating) best practices have already been identified. This and the lack of a built-in data collection system and the difficulty in assessing these most elusive
future of medicine